Polypharmacy and comorbidity in heart failure
- PMID: 12958085
- PMCID: PMC192833
- DOI: 10.1136/bmj.327.7414.513
Polypharmacy and comorbidity in heart failure
References
-
- Remme WJ, Swedberg K. Task Force for the Diagnosis and Treatment of Chronic Heart Failure, European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 2001;22: 1527-60. - PubMed
-
- Hunt HA, Baker DW, Chin MH, Cinquegrani MP, Feldman AM, Francis GS, et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee to revise the 1995 guidelines for the evaluation and management of heart failure): developed in collaboration with the International Society for Heart and Lung Transplantation; endorsed by the Heart Failure Society of America. Circulation 2001;104: 2996-3007. - PubMed
-
- American Heart Association. Heart and Stroke Statistics—2003 update. Dallas, TX: American Heart Association, 2002.
-
- Cleland JG, Cohen-Solal A, Aguilar JC, Dietz R, Eastaugh J, Follath F, et al. Management of heart failure in primary care (the IMPROVEMENT of heart failure programme): an international survey. Lancet 2002;360: 1631-9. - PubMed
-
- Havranek EP, Masoudi FA, Westfall KA, Wolfe P, Ordin DL, Krumholz HM. Spectrum of heart failure in older patients: results from the national heart failure project. Am Heart J 2002;143: 412-7. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical